Volume 23 - Issue 9 - September 2015
Department
Board Review
09/21/2015
1. The absence of co-existent urticaria suggests which diagnosis?
a) Angiotensin-converting enzyme inhibitor-associated angioedema
b) Allergic (IgE-mediated angioedema)
c) Aspirin or non-steroidal anti-inflammatory...
1. The absence of co-existent urticaria suggests which diagnosis?
a) Angiotensin-converting enzyme inhibitor-associated angioedema
b) Allergic (IgE-mediated angioedema)
c) Aspirin or non-steroidal anti-inflammatory...
1. The absence of co-existent...
09/21/2015
The Dermatologist
Column
Spotlight
09/21/2015
Dr. Ring started his career as an immunologist and then worked in allergy research, before becoming a dermatologist.
Dr. Ring started his career as an immunologist and then worked in allergy research, before becoming a dermatologist.
Dr. Ring started his career as...
09/21/2015
The Dermatologist
Chief Medical Editor Message
09/21/2015
Behavioral psychology may provide a host of ways to enhance our relationships with patients.
Behavioral psychology may provide a host of ways to enhance our relationships with patients.
Behavioral psychology may...
09/21/2015
The Dermatologist
News
News
09/21/2015
The FDA has accepted for review a supplemental Biologics License Application (sBLA) for anti-PD-1 therapy pembrolizumab (Keytruda, Merck) for the first-line treatment of unresectable or metastatic melanoma patients. The FDA granted priority...
The FDA has accepted for review a supplemental Biologics License Application (sBLA) for anti-PD-1 therapy pembrolizumab (Keytruda, Merck) for the first-line treatment of unresectable or metastatic melanoma patients. The FDA granted priority...
The FDA has accepted for...
09/21/2015
The Dermatologist
